These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3057092)

  • 1. Immunological response to immunotherapy for immediate hypersensitivity: clinical relevance.
    Tamir R; Pick AI
    Immunol Res; 1988; 7(3):256-64. PubMed ID: 3057092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen-specific immunotherapy: update on immunological mechanisms.
    Alvaro M; Sancha J; Larramona H; Lucas JM; Mesa M; Tabar AI; Martinez-Cañavate A; ;
    Allergol Immunopathol (Madr); 2013; 41(4):265-72. PubMed ID: 23332741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune mechanisms in allergen-specific immunotherapy.
    Rocklin RE
    Clin Immunol Immunopathol; 1989 Nov; 53(2 Pt 2):S119-31. PubMed ID: 2477183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of interleukin 10 in the regulation of allergic immune responses.
    Bellinghausen I; Knop J; Saloga J
    Int Arch Allergy Immunol; 2001 Oct; 126(2):97-101. PubMed ID: 11729346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with a combination of anti-IgE and specific immunotherapy for allergic rhinitis and asthma.
    Hamelmann E; Rolinck-Werninghaus C; Wahn U; Kopp MV
    Arb Paul Ehrlich Inst Bundesinstitut Impfstoffe Biomed Arzneim Langen Hess; 2009; 96():303-13; discussion 313-5. PubMed ID: 20799475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chapter 3: Allergen immunotherapy: definition, indication, and reactions.
    Georgy MS; Saltoun CA
    Allergy Asthma Proc; 2012; 33 Suppl 1():9-11. PubMed ID: 22794676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cc-chemokine eotaxin as a marker of efficacy of specific immunotherapy in patients with intermittent IgE-mediated allergic rhinoconjunctivitis.
    Jahnz-Rózyk K; Targowski T; Głodzinska-Wyszogrodzka E; Płusa T
    Allergy; 2003 Jul; 58(7):595-601. PubMed ID: 12823117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarized TH1 responses by liposome-entrapped allergen and its potential in immunotherapy of allergic disorders.
    Sehra S; Chugh L; Gangal SV
    Clin Exp Allergy; 1998 Dec; 28(12):1530-7. PubMed ID: 10024225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of atopic rhinitis in children with an accelerated variant of specific immunotherapy].
    Gamzatova AA; Gadzhimirzaev GA
    Vestn Otorinolaringol; 1994; (5-6):33-7. PubMed ID: 7856017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope peptides and immunotherapy.
    Tanabe S
    Curr Protein Pept Sci; 2007 Feb; 8(1):109-18. PubMed ID: 17305564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy.
    Fox EM; Torrero MN; Evans H; Mitre E
    J Allergy Clin Immunol; 2015 May; 135(5):1341-51.e1-7. PubMed ID: 25282017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic changes associated with allergen immunotherapy.
    Durham SR; Till SJ
    J Allergy Clin Immunol; 1998 Aug; 102(2):157-64. PubMed ID: 9723654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological changes during specific immunotherapy of grass pollen allergy: reduced lymphoproliferative responses to allergen and shift from TH2 to TH1 in T-cell clones specific for Phl p 1, a major grass pollen allergen.
    Ebner C; Siemann U; Bohle B; Willheim M; Wiedermann U; Schenk S; Klotz F; Ebner H; Kraft D; Scheiner O
    Clin Exp Allergy; 1997 Sep; 27(9):1007-15. PubMed ID: 9678832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological mechanisms operative in allergen-specific immunotherapy.
    Ebner C
    Int Arch Allergy Immunol; 1999 May; 119(1):1-5. PubMed ID: 10341314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen-specific conventional immunotherapy decreases immunoglobulin E-mediated basophil histamine releasability.
    Shim JY; Kim BS; Cho SH; Min KU; Hong SJ
    Clin Exp Allergy; 2003 Jan; 33(1):52-7. PubMed ID: 12534549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunologic studies in allergic children].
    Urbanek R
    Fortschr Med; 1981 Sep; 99(34):1367-9. PubMed ID: 7286882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody response pattern (specific IgE and IgG) of insect sting allergic patients in immunotherapy with venom preparations].
    Wüthrich B; Arrendal H; Lanner A
    Schweiz Med Wochenschr; 1981 Nov; 111(46):1756-65. PubMed ID: 7313646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of immunotherapy on histamine release and other immunological parameters of immediate hypersensitivity in pollinosis.
    Diéguez I; Sanz ML; Oehling A
    J Investig Allergol Clin Immunol; 1993; 3(2):64-71. PubMed ID: 7506622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergen-antibody complexes can efficiently prevent seasonal rhinitis and asthma in grass pollen hypersensitive patients. Allergen-antibody complex immunotherapy.
    Machiels JJ; Somville MA; Jacquemin MG; Saint-Remy JM
    Allergy; 1991 Jul; 46(5):335-48. PubMed ID: 1928657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies.
    Mothes N; Heinzkill M; Drachenberg KJ; Sperr WR; Krauth MT; Majlesi Y; Semper H; Valent P; Niederberger V; Kraft D; Valenta R
    Clin Exp Allergy; 2003 Sep; 33(9):1198-208. PubMed ID: 12956739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.